| Dr Mounir Boutros, MD | |
|
5951 Renaissance Pl, Suite C, Toledo, OH 43623-4722 | |
| (419) 824-2288 | |
| (419) 824-2287 |
| Full Name | Dr Mounir Boutros |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 38 Years |
| Location | 5951 Renaissance Pl, Toledo, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235105941 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 35062133B (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mounir Boutros Md Inc | 2860561321 | 2 |
News Archive
Novo Nordisk today announces the launch of ‘Cities Changing Diabetes', an ambitious new partnership programme to fight the urban diabetes challenge. The ‘Cities Changing Diabetes' programme will first be launched in Mexico City with other cities in North America, Europe and Asia soon to follow.
According to the World Health Organization, two billion people around the globe suffer from chronic parasitic worm infections, which, in addition to causing illness and developmental delay, are also suspected to interfere with the effectiveness of ordinary vaccines, making their victims more vulnerable to life-threatening diseases. A recent discovery by researchers at the Trudeau Institute promises to bypass these obstacles and help deliver more effective vaccines to these people, boosting their protection against common childhood diseases.
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today will present Phase 3 results that showed osteoarthritis (OA) patients treated with investigational SoluMatrix meloxicam 5 mg and 10 mg, a low dose nonsteroidal anti-inflammatory drug (NSAID), reported significantly greater pain relief compared with placebo.
UnitedHealth Group today reported third quarter results, including strong revenue growth in both its Health Benefits and Health Services business groups. Third quarter 2010 net earnings were $1.14 per share. Key performance metrics and costs were in line with or better than Company expectations.
Heralded as a genetically modified crop with the potential to save millions of lives, Golden Rice has just been approved as safe for human and animal consumption by regulators in the Philippines.
› Verified 9 days ago
| Entity Name | Mounir Boutros Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437181203 PECOS PAC ID: 2860561321 Enrollment ID: O20080523000267 |
News Archive
Novo Nordisk today announces the launch of ‘Cities Changing Diabetes', an ambitious new partnership programme to fight the urban diabetes challenge. The ‘Cities Changing Diabetes' programme will first be launched in Mexico City with other cities in North America, Europe and Asia soon to follow.
According to the World Health Organization, two billion people around the globe suffer from chronic parasitic worm infections, which, in addition to causing illness and developmental delay, are also suspected to interfere with the effectiveness of ordinary vaccines, making their victims more vulnerable to life-threatening diseases. A recent discovery by researchers at the Trudeau Institute promises to bypass these obstacles and help deliver more effective vaccines to these people, boosting their protection against common childhood diseases.
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today will present Phase 3 results that showed osteoarthritis (OA) patients treated with investigational SoluMatrix meloxicam 5 mg and 10 mg, a low dose nonsteroidal anti-inflammatory drug (NSAID), reported significantly greater pain relief compared with placebo.
UnitedHealth Group today reported third quarter results, including strong revenue growth in both its Health Benefits and Health Services business groups. Third quarter 2010 net earnings were $1.14 per share. Key performance metrics and costs were in line with or better than Company expectations.
Heralded as a genetically modified crop with the potential to save millions of lives, Golden Rice has just been approved as safe for human and animal consumption by regulators in the Philippines.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mounir Boutros, MD 5951 Renaissance Pl, Suite C, Toledo, OH 43623-4722 Ph: (419) 824-2288 | Dr Mounir Boutros, MD 5951 Renaissance Pl, Suite C, Toledo, OH 43623-4722 Ph: (419) 824-2288 |
News Archive
Novo Nordisk today announces the launch of ‘Cities Changing Diabetes', an ambitious new partnership programme to fight the urban diabetes challenge. The ‘Cities Changing Diabetes' programme will first be launched in Mexico City with other cities in North America, Europe and Asia soon to follow.
According to the World Health Organization, two billion people around the globe suffer from chronic parasitic worm infections, which, in addition to causing illness and developmental delay, are also suspected to interfere with the effectiveness of ordinary vaccines, making their victims more vulnerable to life-threatening diseases. A recent discovery by researchers at the Trudeau Institute promises to bypass these obstacles and help deliver more effective vaccines to these people, boosting their protection against common childhood diseases.
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today will present Phase 3 results that showed osteoarthritis (OA) patients treated with investigational SoluMatrix meloxicam 5 mg and 10 mg, a low dose nonsteroidal anti-inflammatory drug (NSAID), reported significantly greater pain relief compared with placebo.
UnitedHealth Group today reported third quarter results, including strong revenue growth in both its Health Benefits and Health Services business groups. Third quarter 2010 net earnings were $1.14 per share. Key performance metrics and costs were in line with or better than Company expectations.
Heralded as a genetically modified crop with the potential to save millions of lives, Golden Rice has just been approved as safe for human and animal consumption by regulators in the Philippines.
› Verified 9 days ago
Dr. David J Kouba, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4235 Secor Road, Toledo, OH 43623 Phone: 419-479-5795 Fax: 419-479-5797 | |
Ana Marie Thompson, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4126 N Holland Sylvania Rd, Suite 200, Toledo, OH 43623 Phone: 417-473-3257 Fax: 419-473-8816 | |
Dr. Matthew A Molenda, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2000 Regency Ct Ste 201, Toledo, OH 43623 Phone: 419-948-3376 Fax: 419-665-3632 | |
Nancy Parquet, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3000 Arlington Ave, Toledo, OH 43614 Phone: 419-383-4501 | |
Thomas K Dillon, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 6591 W Central Ave, Ste 105, Toledo, OH 43617 Phone: 419-841-9551 Fax: 419-841-9276 | |
Erin Lowe Heuring, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4204 W Sylvania Ave Ste 100, Toledo, OH 43623 Phone: 567-225-3407 Fax: 567-225-3408 |